Literature DB >> 28232077

Genetic causes and mechanisms of Osteogenesis Imperfecta.

Joohyun Lim1, Ingo Grafe1, Stefanie Alexander1, Brendan Lee2.   

Abstract

Osteogenesis Imperfecta (OI) is a genetic disorder characterized by various clinical features including bone deformities, low bone mass, brittle bones, and connective tissue manifestations. The predominant cause of OI is due to mutations in the two genes that encode type I collagen. However, recent advances in sequencing technology has led to the discovery of novel genes that are implicated in recessive and dominant OI. These include genes that regulate the post-translational modification, secretion and processing of type I collagen as well as those required for osteoblast differentiation and bone mineralization. As such, OI has become a spectrum of genetic disorders informing about the determinants of both bone quantity and quality. Here we summarize the known genetic causes of OI, animal models that recapitulate the human disease and mechanisms that underlie disease pathogenesis. Additionally, we discuss the effects of disrupted collagen networks on extracellular matrix signaling and its impact on disease progression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Collagen type I; Extracellular matrix; Osteoblast; Osteogenesis Imperfecta; TGF-β signaling

Mesh:

Substances:

Year:  2017        PMID: 28232077      PMCID: PMC5607741          DOI: 10.1016/j.bone.2017.02.004

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  143 in total

Review 1.  Building strong bones: molecular regulation of the osteoblast lineage.

Authors:  Fanxin Long
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

2.  Influence of decorin expression on transforming growth factor-beta-mediated collagen gel retraction and biglycan induction.

Authors:  A Markmann; H Hausser; E Schönherr; H Kresse
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

3.  Activation of the bone-derived latent TGF beta complex by isolated osteoclasts.

Authors:  R O Oreffo; G R Mundy; S M Seyedin; L F Bonewald
Journal:  Biochem Biophys Res Commun       Date:  1989-02-15       Impact factor: 3.575

4.  Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta.

Authors:  J Saban; M A Zussman; R Havey; A G Patwardhan; G B Schneider; D King
Journal:  Bone       Date:  1996-12       Impact factor: 4.398

5.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

6.  Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse.

Authors:  I Kalajzic; J Terzic; Z Rumboldt; K Mack; A Naprta; F Ledgard; G Gronowicz; S H Clark; D W Rowe
Journal:  Endocrinology       Date:  2002-05       Impact factor: 4.736

7.  Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation.

Authors:  Tomohiko Murakami; Atsushi Saito; Shin-ichiro Hino; Shinichi Kondo; Soshi Kanemoto; Kazuyasu Chihara; Hiroshi Sekiya; Kenji Tsumagari; Kimiko Ochiai; Kazuya Yoshinaga; Masahiro Saitoh; Riko Nishimura; Toshiyuki Yoneda; Ikuyo Kou; Tatsuya Furuichi; Shiro Ikegawa; Masahito Ikawa; Masaru Okabe; Akio Wanaka; Kazunori Imaizumi
Journal:  Nat Cell Biol       Date:  2009-09-20       Impact factor: 28.824

8.  Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength.

Authors:  Kenneth M Kozloff; Angela Carden; Clemens Bergwitz; Antonella Forlino; Thomas E Uveges; Michael D Morris; Joan C Marini; Steven A Goldstein
Journal:  J Bone Miner Res       Date:  2004-01-12       Impact factor: 6.741

9.  Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.

Authors:  A Carriero; M Doube; M Vogt; B Busse; J Zustin; A Levchuk; P Schneider; R Müller; S J Shefelbine
Journal:  Bone       Date:  2013-12-27       Impact factor: 4.398

10.  WNT7B promotes bone formation in part through mTORC1.

Authors:  Jianquan Chen; Xiaolin Tu; Emel Esen; Kyu Sang Joeng; Congxin Lin; Jeffrey M Arbeit; Markus A Rüegg; Michael N Hall; Liang Ma; Fanxin Long
Journal:  PLoS Genet       Date:  2014-01-30       Impact factor: 5.917

View more
  27 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

2.  Health-related quality of life in children with osteogenesis imperfecta: a large-sample study.

Authors:  Y Song; D Zhao; L Li; F Lv; O Wang; Y Jiang; W Xia; X Xing; M Li
Journal:  Osteoporos Int       Date:  2018-12-19       Impact factor: 4.507

3.  Skeletal fragility: an emerging complication of Ehlers-Danlos syndrome.

Authors:  Anna Maria Formenti; Mauro Doga; Stefano Frara; Marco Ritelli; Marina Colombi; Giuseppe Banfi; Andrea Giustina
Journal:  Endocrine       Date:  2018-12-15       Impact factor: 3.633

Review 4.  Osteogenesis imperfecta: advancements in genetics and treatment.

Authors:  Vittoria Rossi; Brendan Lee; Ronit Marom
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

5.  Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.

Authors:  Y Song; D Zhao; X Xu; F Lv; L Li; Y Jiang; O Wang; W Xia; X Xing; M Li
Journal:  Osteoporos Int       Date:  2018-03-09       Impact factor: 4.507

6.  Efficacy of teriparatide vs neridronate in adults with osteogenesis imperfecta type I: a prospective randomized international clinical study.

Authors:  Paolo Tranquilli Leali; Massimo Balsano; Gianluca Maestretti; Matteo Brusoni; Veronica Amorese; Emanuele Ciurlia; Matteo Andreozzi; Gianfilippo Caggiari; Carlo Doria
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

Review 7.  An Update on Animal Models of Osteogenesis Imperfecta.

Authors:  Fang Lv; Xiaoling Cai; Linong Ji
Journal:  Calcif Tissue Int       Date:  2022-06-29       Impact factor: 4.000

8.  Intrafibrillar mineralization deficiency and osteogenesis imperfecta mouse bone fragility.

Authors:  Mohammad Maghsoudi-Ganjeh; Jitin Samuel; Abu Saleh Ahsan; Xiaodu Wang; Xiaowei Zeng
Journal:  J Mech Behav Biomed Mater       Date:  2021-02-13

Review 9.  Collagen transport and related pathways in Osteogenesis Imperfecta.

Authors:  Lauria Claeys; Silvia Storoni; Marelise Eekhoff; Mariet Elting; Lisanne Wisse; Gerard Pals; Nathalie Bravenboer; Alessandra Maugeri; Dimitra Micha
Journal:  Hum Genet       Date:  2021-06-24       Impact factor: 4.132

10.  Localized chondro-ossification underlies joint dysfunction and motor deficits in the Fkbp10 mouse model of osteogenesis imperfecta.

Authors:  Joohyun Lim; Caressa Lietman; Matthew W Grol; Alexis Castellon; Brian Dawson; Mary Adeyeye; Jyoti Rai; MaryAnn Weis; Douglas R Keene; Ronen Schweitzer; Dongsu Park; David R Eyre; Deborah Krakow; Brendan H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.